SCHEMBL6959379

SCHEMBL6959379

CN(CCN1CCOCC1)c1nsc2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 1/20 0.42
▸ SLC6A4 P31645 1/20 0.42
▸ GRM4 Q14833 2/20 0.41
▸ KDM1A O60341 1/20 0.41
▸ LMNA P02545 2/20 0.41
▸ CHRM3 P20309 1/20 0.40
▸ GAA P10253 2/20 0.40
▸ USP2 O75604 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ HRH3 Q9Y5N1 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.39
▸ DRD2 P14416 2/20 0.39
▸ DRD3 P35462 2/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ OPRM1 P35372 1/20 0.39
▸ PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3505352 0.77 LMNA (0.42) GRM4LMNACHRM3GAAUSP2
SCHEMBL11440371 0.73 HTR7 (0.53) KDM1ALMNAMEN1ALDH1A1KMT2A
SCHEMBL18090296 0.72 GAA (0.46) GRM4LMNAGAAUSP2MEN1
SCHEMBL12125000 0.71 MAPT (0.46) LMNAALDH1A1
SCHEMBL6653067 0.68 CYP3A4 (0.47) GRM4LMNAGAAALDH1A1PKM
SCHEMBL27348854 0.68 NTSR1 (0.43) KDM1ALMNACHRM3MEN1KMT2A
SCHEMBL950462 0.67 GRM4 (0.39) GRM4KDM1ALMNACHRM3GAA
SCHEMBL13103802 0.66 POLB (0.48) ALDH1A1
SCHEMBL3504376 0.66 GRM4 (0.41) GRM4LMNAGAAALDH1A1HTR2A
SCHEMBL9386764 0.66 LMNA (0.37) GRM4LMNACHRM3GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0669920-B1 SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS AVENTIS PHARMA INC (US) 2003-02-12 — — EP disclosed
US-5925766-A COGNITION ACTIVATORS FOR DECREASING CHOLINERGIC FUNCTION OF ALZHEIMER*S DISEASE AND ARE ENZYME INHIBITORS OF MONOAMINE OXIDASE AND ARE ANTIDEPRESSANTS HOECHST MARION ROUSSEL, INC. (US) 1999-07-20 — — US disclosed
US-5756754-A Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds HOECHST MARION ROUSSEL, INC. (US) 1998-05-26 — — US disclosed
US-5580982-A ANTIDEPRESSANTS; ANTICHOLINERGIC AGENTS; ALZHEIMER'S DISEASE; AMINE OXIDASE INHIBITORS HOECHST MARION ROUSSEL INC. (US) 1996-12-03 — — US disclosed
US-5494908-A ANTIDEPRESSANT HOECHST-ROUSSEL PHARMACEUTICAL INCORPORATED (US) 1996-02-27 — — US disclosed
WO-1994012495-A1 SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1994-06-09 — — WO disclosed
Send feedback